MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bjh.13614

Медицинская библиотека · British journal of haematology · 2015

Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.

Dufour Carlo, Veys Paul, Carraro Elisa, Bhatnagar Neha, Pillon Marta, Wynn Rob, Gibson Brenda, Vora Ajay J, Steward Colin G, Ewins Anna M, Hough Rachael E, de la Fuente Josu, Velangi Mark, Amrolia Persis J, Skinner Roderick, Bacigalupo Andrea, Risitano Antonio M, Socie Gerard, Peffault de Latour Regis, Passweg Jakob, Rovo Alicia, Tichelli André, Schrezenmeier Hubert, Hochsmann Britta, Bader Peter, van Biezen Anja, Aljurf Mahmoud D, Kulasekararaj Austin, Marsh Judith C, Samarasinghe Sujith

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

We explored the feasibility of unrelated donor haematopoietic stem cell transplant (HSCT) upfront without prior immunosuppressive therapy (IST) in paediatric idiopathic severe aplastic anaemia (SAA). This cohort was then compared to matched historical controls who had undergone first-line therapy with a matched sibling/family donor (MSD) HSCT (n = 87) or IST with horse antithymocyte globulin and ciclosporin (n = 58) or second-line therapy with unrelated donor HSCT post-failed IST (n = 24). The 2-year overall survival in the upfront cohort was 96 ± 4% compared to 91 ± 3% in the MSD controls (P = 0·30) and 94 ± 3% in the IST controls (P = 0·68) and 74 ± 9% in the unrelated donor HSCT post-IST failure controls (P = 0·02).The 2-year event-free survival in the upfront cohort was 92 ± 5% compared to 87 ± 4% in MSD controls (P = 0·37), 40 ± 7% in IST controls (P = 0·0001) and 74 ± 9% in the unrelated donor HSCT post-IST failure controls (n = 24) (P = 0·02). Outcomes for upfront-unrelated donor HSCT in paediatric idiopathic SAA were similar to MSD HSCT and superior to IST and unrelated donor HSCT post-IST failure. Front-line therapy with matched unrelated donor HSCT is a novel treatment approach and could be considered as first-line therapy in selected paediatric patients who lack a MSD.

Для цитирования: Dufour Carlo, Veys Paul, Carraro Elisa, Bhatnagar Neha, Pillon Marta, Wynn Rob, Gibson Brenda, Vora Ajay J, Steward Colin G, Ewins Anna M, Hough Rachael E, de la Fuente Josu, Velangi Mark, Amrolia Persis J, Skinner Roderick, Bacigalupo Andrea, Risitano Antonio M, Socie Gerard, Peffault de Latour Regis, Passweg Jakob, Rovo Alicia, Tichelli André, Schrezenmeier Hubert, Hochsmann Britta, Bader Peter, van Biezen Anja, Aljurf Mahmoud D, Kulasekararaj Austin, Marsh Judith C, Samarasinghe Sujith. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.. British journal of haematology. 2015. DOI: 10.1111/bjh.13614.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.